| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.13 | 6e-05 |